An immune response can be activated by pathogenic stimuli, as well as endogenous danger signals, triggering the activation of pattern recognition receptors and initiating signalling cascades that lead to inflammation. This method uses THP1-Blue™ cells, a human monocytic cell line which contains an embryonic alkaline phosphatase reporter gene allowing the detection of NF-κBinduced transcriptional activation. We validated this protocol by assessing NF-κB activation after stimulation of toll-like receptor 4 (TLR4) by two different agonists: lipopolysaccharide (LPS), derived from the cell wall of Gram negative bacteria, and tenascin-C, an extracellular matrix protein whose expression is induced upon tissue injury. We then used this protocol to screen for potential new endogenous TLR4 agonists, but this method can also be used as a quick, economical and reliable means to assay the activity of other inflammatory stimuli resulting in TLR-dependent NF-κB activation.
Background
The immune system has evolved to recognize not only pathogenic stimuli such as bacterial components and viral nucleic acids, but also endogenous danger signals including proteins secreted from necrotic cells or expressed upon tissue damage. Both types of stimuli are sensed by pattern recognition receptors, initiating signalling cascades that trigger inflammatory responses. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a transcription factor essential for the activation of the immune response to infection and tissue damage. NF-κB has an important role in the expression of a wide range of inflammatory mediators following pattern recognition receptor activation, including cytokines (such as tumour necrosis factor α [TNFα], interleukin-6 and interleukin-1), chemokines (e.g., interleukin-8 or CXCL1), proteases, growth factors and MHC-related molecules, among others. To assess the activation of this pathway downstream of TLR4, we used the commercially available cell line THP1-Blue™ NF-κB (Invivogen). These cells are stably transfected with a construct containing a secreted embryonic alkaline phosphatase (SEAP) gene induced by the NF-κB transcription factor. The construct contains an interferon-β minimal promoter fused to five copies of the NF-κB consensus transcriptional response element and three copies of the c-Rel binding site, which drives the expression of the reporter gene. After cell stimulation with pathogenic or endogenous stimuli, NF-κB activation leads to the secretion of SEAP, which is then quantified using the colorimetric reagent QUANTI-Blue™. This is a quick and reliable method to assess activation of NF-κB downstream of toll-like receptors, as the amount of SEAP in the media correlates with the triggering of this signalling pathway. However, this is an engineered cell line that does not express a full complement of inflammatory effector molecules (see Note 5), and so whilst useful in screening for NF-κB activation, data should always be confirmed in additional experimental systems, for example in primary macrophages, or in vivo.
Materials and Reagents

1.
Pipette tips 20 µl (StarLabs, TipOne ® , catalog number: S1110-3800)
200 µl (StarLabs, TipOne ® , catalog number: S1111-0806) 1,000 µl (StarLabs, TipOne ® , catalog number: S1111-6801)
2.
Corning 15 ml PP centrifuge sterile tubes (Corning, catalog number: 430791)
3.
Cell culture flask 75 cm 2 (VWR, catalog number: 734-0012)
4.
96 well plate flat-bottom (VWR, catalog number: 734-0023)
5.
THP1-Blue™ NF-κB cells (InvivoGen, catalog number: thp-nfkb)
6.
Positive control: LPS from E. coli, Serotype EH100 (Ra) (TLRgrade™) (Enzo life sciences, catalog number: ALX-581-010-L002)
7.
Test inflammatory stimulus: for example recombinant tenascin-C protein or the fibrinogen like globe domain (FBG) of tenascin-C protein (synthesized as described in Midwood et al., 2009) 
8.
Roswell Park Memorial Institute (RPMI) 1640 with L-glutamine (Lonza, catalog number: BE12-702F)
9.
Fetal bovine serum (FBS), Qualified, heat inactivated (Thermo Fisher Scientific, Gibco™, catalog number: 10500064)
10.
Penicillin/streptomycin (Thermo Fisher Scientific, Gibco™, catalog number: 15140122)
11.
Normocin™ (InvivoGen, catalog number: ant-nr-1)
12.
Blasticidin HCl (Thermo Fisher Scientific, Gibco™, catalog number: R21001)
13.
QUANTI-Blue™ (InvivoGen, catalog number: rep-qb1)
14.
ThP1 media without blasticidin (see Recipes)
15.
ThP1 media with blasticidin (see Recipes)
16.
QUANTI-Blue™ solution (see Recipes) Equipment 
1.
Thaw a vial containing 3-7 x 10 6 THP1-Blue™ NF-κB cells in a 37 °C water bath.
2.
Transfer cells to a 15 ml sterile tube containing 10 ml of pre-warmed ThP1 NF-κB medium without blasticidin (see Recipes). Centrifuge tube at 320 x g for 5 min.
3.
Remove supernatant and resuspend cells in 10 ml of ThP1 NF-κB medium without blasticidin. Count the cells using a hemocytometer.
4.
Transfers 1 x 10 6 cells in 10 ml of ThP1 NF-κB medium without blasticidin to a 75 cm 2 cell culture flask and place the culture at 37 °C in 5% CO 2 .
5.
The cells grow in suspension. To passage the cells, transfer cells to a sterile 15 ml tube and measure cell concentration using a hemocytometer. Centrifuge tube at 320 x g for 5 min at room temperature, remove cell supernatant and resuspend cells in fresh media. Passage the cells every 3 days and do not let the cell concentration in the flask exceed 2 x 10 6 cells/ml.
6.
For the first two passages, cells should be cultured in medium without blasticidin to allow recovery from freezing. After the second passage, 
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B.
Cell stimulation
1.
Transfer cells to a 15 ml sterile tube. Centrifuge cells at 320 x g for 5 min. Remove supernatant and resuspend cells in new ThP1 NF-κB medium with blasticidin.
2.
Plate 1 x 10 5 cells per well in a flat-bottom 96 well plate in a final volume of 100 µl.
3.
Immediately after plating, stimulate cells by adding LPS or recombinant protein (e.g., FBG) diluted in 100 µl of media in duplicate or triplicate wells. The final volume in each well is 200 µl.
4.
Incubate the cells for 24 h at 37 °C in 5% CO 2 (see Note 3).
5.
To measure NF-κB-induced secreted alkaline phosphatase, collect cell supernatant.
6.
At this stage cells can be taken for assessment of viability for example by MTT assay.
C.
Measurement of NF-κB activation
1.
Warm QUANTI-Blue™ solution (see Recipes) at 37 °C for 10 min.
2.
Add 180 µl of QUANTI-Blue™ per well to a flat-bottom 96 well plate.
3.
Add 20 µl of THP1-Blue™ cell supernatant to each well.
4.
Incubate the plate at 37 °C for 2 h. The media will change color from pink to blue in the presence of secreted embryonic alkaline phosphatase (Figure 1 ).
5.
Determine SEAP levels by reading the optical density (OD) at 620 nm using a spectrophotometer plate reader.
Data analysis
For each stimulus, plot the mean of OD values ± standard error of the mean (SEM), in the case of multiple independent experiments (Figure 2 ), or the mean of OD values ± standard deviation (SD), in the case of single experiments. The data can also be represented as fold change difference compared to non-stimulated cells. Perform statistical analysis using Graph Pad Prism or other software.
Notes
1.
QUANTI-Blue™ signal can be detected between 15 min to 24 h after adding cell supernatant. Determine the optimal time point for measuring QUANTI-Blue™ signal to be able to compare between independent experiments.
2.
THP1-Blue™ NF-κB cells respond robustly to TLR1/2, TLR2/6, TLR4, TLR5, TLR8, NOD1 and NOD2 agonists. However, poor responses have been observed with TLR3, TLR7 and TLR9 ligands.
3.
Robust SEAP signal can be detected from 8 h after cell stimulation with TLR4 ligands (Figure 3 ). Nevertheless, it is recommended to titrate the stimulus of interest to determine the optimal dose and time point after stimulation to assess NF-κB activation.
4.
THP1-Blue™ NF-κB cells should not be used after the 12 th passage (Figure 4) . According to the manufacturer (Invivogen), these cells undertake genotypic changes that result in reduced responsiveness over time under normal culture conditions. It is important to prepare frozen stocks at early passages.
5.
THP1-Blue™ NF-κB cells cannot be used to assess cytokine protein expression. No cytokines can be reliably detected in the supernatant of these cells after activation with LPS ( Figure 5 ).
6.
When testing the inflammatory activity of recombinant proteins, the LPS content of preparations should be < 10 pg/ml. Additional controls that should be included are 1) incubation of the recombinant protein with polymyxin B, an antibiotic that inhibits pathogenic activation of TLR4, but which doesn't affect the recombinant protein activity; and 2) boiling the samples, which doesn't affect LPS activity, but denatures the protein, destroying its pro-inflammatory activity ( Figure 6 ). Pour the content of one pouch of QUANTI-Blue™ in a sterile flask with 100 ml of endotoxin-free water. Incubate QUANTI-Blue™ solution at 37 °C for 30 min and swirl gently every 10 min to dissolve the powder. QUANTI-Blue™ solution is stable for 2 weeks at 2-8 °C, or two month at -20 °C. Keep reconstituted QUANTI-Blue™ away from light
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